BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17157627)

  • 1. Ovarian cancer.
    Mironov S; Akin O; Pandit-Taskar N; Hann LE
    Radiol Clin North Am; 2007 Jan; 45(1):149-66. PubMed ID: 17157627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging techniques for the evaluation of ovarian cancer.
    Fischerova D; Burgetova A
    Best Pract Res Clin Obstet Gynaecol; 2014 Jul; 28(5):697-720. PubMed ID: 24846098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT.
    Kim CK; Park BK; Choi JY; Kim BG; Han H
    J Comput Assist Tomogr; 2007; 31(6):868-75. PubMed ID: 18043348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [18F-FDG PET/CT in patients, treated for ovarian cancer, with elevated CA 125 levels but no evidence of recurrence on conventional imaging].
    Bochev P; Bocheva Y; Klisarova A; Ivanov S; Dancheva J; Chaushev B
    Akush Ginekol (Sofiia); 2012; 51(1):18-27. PubMed ID: 22639775
    [No Abstract]   [Full Text] [Related]  

  • 5. [Value of positron emission tomography-CT imaging combined with continual detection of CA125 in serum for diagnosis of early asymptomatic recurrence of epithelial ovarian carcinoma].
    Sheng XG; Zhang XL; Fu Z; Li HQ; Li QS; Ma ZF; Li DP; Chen ZY
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):460-3. PubMed ID: 17961335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian cancer: detection and radiologic staging.
    Shaaban A; Rezvani M
    Clin Obstet Gynecol; 2009 Mar; 52(1):73-93. PubMed ID: 19179862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multidisciplinary approach to ovarian cancer at diagnosis.
    Spencer JA
    Br J Radiol; 2005; 78 Spec No 2():S94-102. PubMed ID: 16306641
    [No Abstract]   [Full Text] [Related]  

  • 8. Imaging of prostate cancer.
    Akin O; Hricak H
    Radiol Clin North Am; 2007 Jan; 45(1):207-22. PubMed ID: 17157630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CT in the evaluation of ovarian malignancy.
    Amendola MA
    Crit Rev Diagn Imaging; 1985; 24(4):329-68. PubMed ID: 3896652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDG-PET for management of cervical and ovarian cancer.
    Havrilesky LJ; Kulasingam SL; Matchar DB; Myers ER
    Gynecol Oncol; 2005 Apr; 97(1):183-91. PubMed ID: 15790456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic value of magnetic resonance imaging for the detection of tumor recurrence in patients with carcinoma of the ovaries.
    Kainz C; Prayer L; Gitsch G; Stiglbauer R; Kramer J; Reinthaller A; Kölbl H
    J Am Coll Surg; 1994 Mar; 178(3):239-44. PubMed ID: 8149015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging of uterine cancer.
    Akin O; Mironov S; Pandit-Taskar N; Hann LE
    Radiol Clin North Am; 2007 Jan; 45(1):167-82. PubMed ID: 17157628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy- D-glucose.
    Torizuka T; Nobezawa S; Kanno T; Futatsubashi M; Yoshikawa E; Okada H; Takekuma M; Maeda M; Ouchi Y
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):797-803. PubMed ID: 12029554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125.
    Rubini G; Altini C; Notaristefano A; Merenda N; Rubini D; Ianora AA; Asabella AN
    Rev Esp Med Nucl Imagen Mol; 2014; 33(1):22-7. PubMed ID: 23948509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review.
    Makhija S; Howden N; Edwards R; Kelley J; Townsend DW; Meltzer CC
    Gynecol Oncol; 2002 Apr; 85(1):53-8. PubMed ID: 11925120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging breast cancer.
    Bartella L; Smith CS; Dershaw DD; Liberman L
    Radiol Clin North Am; 2007 Jan; 45(1):45-67. PubMed ID: 17157623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of bladder cancer.
    Zhang J; Gerst S; Lefkowitz RA; Bach A
    Radiol Clin North Am; 2007 Jan; 45(1):183-205. PubMed ID: 17157629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.
    Castellucci P; Perrone AM; Picchio M; Ghi T; Farsad M; Nanni C; Messa C; Meriggiola MC; Pelusi G; Al-Nahhas A; Rubello D; Fazio F; Fanti S
    Nucl Med Commun; 2007 Aug; 28(8):589-95. PubMed ID: 17625380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes.
    Bristow RE; Giuntoli RL; Pannu HK; Schulick RD; Fishman EK; Wahl RL
    Gynecol Oncol; 2005 Nov; 99(2):294-300. PubMed ID: 16051330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and interventional radiology in gynecologic neoplasms.
    Thorvinger B
    Acta Radiol Suppl; 1992; 378 ( Pt 3)():93-108. PubMed ID: 1323200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.